Clinical Trial Update: A Trial of Camrelizumab Plus Nab-paclitaxel and Levocetirizine in Metastatic or Recurrent TNBC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating camrelizumab plus nab-paclitaxel and levocetirizine for metastatic or recurrent triple-negative breast cancer; currently not y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Camrelizumab (camrelizumab)
• Levocetirizine (Levocetirizine)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Breast Cancer | Phase 2 | Status: NOT_YET_RECRUITING